An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

BACKGROUND: Across Europe, methicillin-resistant Staphylococcus aureus (MRSA) is considered to be the primary cause of nosocomial pneumonia (NP). In Germany alone, approximately 14,000 cases of MRSA-associated NP occur annually, which may have a significant impact on health care resource use and ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Dipen A, Michel, Andre, Stephens, Jennifer, Weber, Bertram, Petrik, Christian, Charbonneau, Claudie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216023/
https://www.ncbi.nlm.nih.gov/pubmed/25368526
http://dx.doi.org/10.2147/IDR.S68658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216023/
https://www.ncbi.nlm.nih.gov/pubmed/25368526
http://dx.doi.org/10.2147/IDR.S68658

Ejemplares similares